SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Novo Nordisk launches Wegovy pill in Germany

Novo Nordisk (NOVOB) has launched its Wegovy oral weight-loss pill in Germany, a spokesperson said, as investors focus on the treatment amid intensifying competition with Eli Lilly (LLY).

LLYNOVOB

Novo Nordisk OMXCOP:NOVO_B has launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday, as investors track the oral weight-loss treatment amid intensifying competition with U.S. rival Eli Lilly NYSE:LLY. Novo was first to bring a highly effective weight-loss drug to market in pill form.

Related stories